Niki BioSolutions, Inc. (NIKI) AI Dilution Summary

Cash was $3,452,891 at the 2025-12-31 balance-sheet date. The active funding channel is an at-the-market program, with H.C. Wainwright & Co., LLC as selling manager, authorised to $1,396,000. Dilution here is driven primarily by that ATM program.